Found: 10
Select item for more details and to access through your institution.
Apoptotic Non–β Cells Suppress β Cell Antigen–Reactive T Cells and Induce β Cell Antigen–Specific Regulatory T Cells.
- Published in:
- Annals of the New York Academy of Sciences, 2008, v. 1150, p. 167, doi. 10.1196/annals.1447.038
- By:
- Publication type:
- Article
Transfusion of Apoptotic β-Cells Induces Immune Tolerance to β-Cell Antigens and Prevents Type 1 Diabetes in NOD Mice.
- Published in:
- Diabetes, 2007, v. 56, n. 8, p. 2116, doi. 10.2337/db06-0825
- By:
- Publication type:
- Article
Intravenous Injection of Apoptotic Cells Prevents Type 1 Diabetes in NOD Mice.
- Published in:
- Diabetes, 2007, v. 56, p. A319
- By:
- Publication type:
- Article
CD47 and Osteopontin Expression in Diffuse Large B-cell Lymphoma With Nodal and Intravascular Involvement.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2013, v. 13, n. 5, p. 597, doi. 10.1016/j.clml.2013.05.001
- By:
- Publication type:
- Article
Large Scale Preparation of β-CaSiO<sub>3</sub> Nanostructures by Solid-State Reaction in NaCl-H<sub>2</sub>O(v) System at Lower Temperature.
- Published in:
- Journal of the American Ceramic Society, 2015, v. 98, n. 7, p. 2264, doi. 10.1111/jace.13524
- By:
- Publication type:
- Article
T-cell/histiocyte-rich large B-cell lymphoma presenting as a primary central nervous system lymphoma.
- Published in:
- Rare Tumors, 2015, v. 7, n. 4, p. 160, doi. 10.4081/rt.2015.6084
- By:
- Publication type:
- Article
Pomalidomide Shows Significant Therapeutic Activity against CNS Lymphoma with a Major Impact on the Tumor Microenvironment in Murine Models.
- Published in:
- PLoS ONE, 2013, v. 8, n. 8, p. 1, doi. 10.1371/journal.pone.0071754
- By:
- Publication type:
- Article
LRRTM3 Interacts with APP and BACE1 and Has Variants Associating with Late-Onset Alzheimer’s Disease (LOAD).
- Published in:
- PLoS ONE, 2013, v. 8, n. 6, p. 1, doi. 10.1371/journal.pone.0064164
- By:
- Publication type:
- Article
Immune checkpoint inhibition by anti‐PDCD1 (anti‐PD1) monoclonal antibody has significant therapeutic activity against central nervous system lymphoma in an immunocompetent preclinical model.
- Published in:
- British Journal of Haematology, 2018, v. 183, n. 4, p. 674, doi. 10.1111/bjh.15009
- By:
- Publication type:
- Article
A Virtual Screening Platform Identifies Chloroethylagelastatin A as a Potential Ribosomal Inhibitor.
- Published in:
- Biomolecules (2218-273X), 2020, v. 10, n. 10, p. 1407, doi. 10.3390/biom10101407
- By:
- Publication type:
- Article